China Economic Net editor's note: The implementation of coronary stent collection, the export of medical devices and medical devices increased, new products continue to be approved... Medical devices started 2021 with frequent moon spots. China Economic Net reporters combed through the major news in the field of medical devices in January 2021 for the benefit of readers.

policy

Coronary stents were collected

On January 1, the national collection of coronary stents was implemented in 18 provinces, autonomous regions and municipalities, including Beijing, Tianjin, Liaoning and Hunan. The 10 selected stents purchased by the national organization "Coronary stents" were reduced by 93% on average. The average price cut for imported products was 95 percent, and for domestic products 92 percent.

Postponing the expert review of configuration and licensing of Class A large medical equipment in 2020

The National Health Commission (NHC) announced on January 28 that according to the COVID-19 epidemic situation and the requirements of epidemic prevention and control, it decided to postpone the expert review of configuration and licensing of Class A large medical equipment in 2020 after study.

Industry market

Exports of medical instruments and instruments soared

According to the data released by the General Administration of Customs on January 14, the total value of imported medical instruments and instruments in 2020 was 87.12 billion yuan, up 1.3% year on year; The value of exported medical instruments and instruments reached RMB125.94 billion, up 41.5% year on year.

The company's net profit for 2020 increased by 3,713.45%

Incare released the 2020 annual performance forecast on January 24. During the reporting period, the net profit attributable to shareholders of the listed company increased by 3713.45%-3993.85% compared with the same period last year. According to the notice, during the reporting period, due to the novel coronavirus epidemic, the global demand for disposable protective gloves surged, and the selling price of the company's disposable protective gloves increased significantly, which greatly increased the company's sales income and gross profit margin during the reporting period. Companies that also announced an increase in full-year results for 2020 due to factors such as the pandemic include Mindray Medical and Zhende Medical.

Dive Medical's revenue increased 45.26% in 2020

Diving Medical (002223.SZ) released the 2020 financial results in the evening of January 28, the company's 2020 annual operating revenue of 6.734 billion yuan, a year-on-year increase of 45.26%; Net profit attributable to shareholders of the listed company was 1.791 billion yuan, up 138.04% year on year; The basic earnings per share is 1.7870 yuan per share.

New product release

"Iliac artery bifurcation Stent System" approved by Xianjian Technology

A medical device developed by China to reconstruct the internal iliac artery has been approved by the National Medical Products Administration on Jan 13. The innovative product produced by Xianjian Technology (Shenzhen) Co., Ltd. is called "iliac artery bifurcation stent system" and is used to treat abdominal or common iliac aneurysms.

On January 13, the state department of pharmaceutical administration announced an innovative medical devices, hunan Mr Put medical instrument co., LTD production of "anchor catheter balloon expansion", the domestic initiative by balloon catheter exchange in the form of anchor can solve micro catheter in percutaneous coronary angioplasty retreat when operating difficulties, thread problems such as shift even dropped out of the lesions.

Major personnel changes

Sinopharm Holding for shuai

On January 14, Sinopharm Pharmaceutical Holding Co., LTD. (Sinopharm Pharmaceutical Holding Co., LTD.) announced that the Board of Directors elected Yu Qingming as Chairman of the Board of Directors, Chairman of the Board of Directors Strategy and Investment Committee, Chairman of the Board of Directors Nomination Committee; Liu Yong was elected member of the Committee of Legal Compliance and Environment, Society and Governance. On January 12, Li Zhiming, chairman of Sinopharm, and Li Hui, director and general manager of Sinopharm, abruptly resigned on the same day, causing concern in the industry.